Clint Mower
Family Medicine · Lehi, UTNPI 1437653854
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,245 of the $41,347 with a category attached, or 73.1%. Johnson & Johnson accounts for 89.7% of it on its own, with 49 other manufacturers making up the rest. Among family medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $122.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$37K
- AbbVie$1K
- AstraZeneca$218
- Lilly USA, LLC$199
- Corcept Therapeutics$173
- Novo Nordisk$172
- plus $2K from 44 others
What the payments were for
- Speaking & faculty fees$30,24573%
- Travel & lodging$5,18913%
- Food & beverage$5,91314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,347 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 13 | $19,133 |
| EliquisApixaban | 12 | $14,275 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $3,706 |
| Omeprazole | 28 | $749 |
| Levothyroxine Sodium | 56 | $726 |
| Quetiapine Fumarate | 25 | $678 |
| Atorvastatin Calcium | 48 | $603 |
| Lisinopril | 54 | $583 |
| Memantine Hcl | 14 | $551 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $489 |
| Sertraline Hcl | 42 | $407 |
| Amlodipine Besylate | 31 | $358 |
| Tamsulosin Hcl | 21 | $357 |
| Gabapentin | 14 | $355 |
| Losartan Potassium | 48 | $344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,229 | $19,13313 claims |
| PfizerEliquis | $93 | $14,27512 claims |
| Almatica Pharma LLCSertraline Hcl | $31 | $40742 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 928 family medicine providers in Utah.
Other family medicine in Lehi
- Toran MacarthurLehi$10K
- Tauaina NgatuvaiLehi$10K
- Cheryl JohnsonLehi$9K
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Scott EricksonBountiful$101K
- Mark CacciamaniSalt Lake City$43K
- Russell AndersonTooele$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.